NIKKEI 225
28,875.23+0.34(+0.00%)HANG SENG
28,882.46+65.39(+0.23%)CRUDE OIL
73.28+0.20(+0.27%)
NOVARTIS AG NOVARTIS ORD SHS (0QLR.IL)
| Previous close | 85.50 |
| Open | 85.15 |
| Bid | 83.00 x N/A |
| Ask | 87.00 x N/A |
| Day's range | 84.51 - 85.51 |
| 52-week range | 24.00 - 308.00 |
| Volume | 967,729 |
| Avg. volume | 666,539 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Globe Newswire
New Zolgensma data demonstrate age-appropriate development when used presymptomatically and rapid, clinically meaningful efficacy in symptomatic children, even those with severe SMA at baseline
All children (100%) treated presymptomatically in the SPR1NT two-copy cohort survived without respiratory or nutritional support, and sat independently for ≥30 seconds, most (11/14) within the WHO window of expected normal development The majority of children (82%) treated in STR1VE-EU achieved developmental motor milestones not observed in the natural history of SMA Type 1, including patients with more severe disease More than 1,200 patients have now been treated with Zolgensma globally across
- Yahoo Finance Video
Influencers with Andy Serwer: David Ricks
In this episode of Influencers, Eli Lilly Chairman & CEO David Ricks joins Andy to discuss the latest in the pharmaceutical industry, new progress in the fight against COVID-19, and potential groundbreaking advancements for the treatment of Alzheimer’s.
- Yahoo Finance Video
By next summer we'll have enough vaccines to vaccinate the world: Eli Lilly CEO
Eli Lilly CEO David Ricks joins 'Influencers with Andy Serwer' to discuss progress in the fight against COVID-19.
